연구동향 분석

Is radiological healing alone enough? ‘Can’t take my eyes off’ the mucosa

Su Hyun Park Sang Hyoung Park 2022년

논문상세정보
    • 저자 Su Hyun Park Sang Hyoung Park
    • 제어번호 108107479
    • 학술지명 The Korean Journal of Internal Medicine
    • 권호사항 Vol. 37 No. 3 [ 2022 ]
    • 발행처 대한내과학회
    • 발행처 URL http://www.kaim.or.kr
    • 자료유형 학술저널
    • 수록면 551-552
    • 언어 English
    • 출판년도 2022
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Is radiological healing alone enough? ‘Can’t take my eyes off’ the mucosa' 의 참고문헌

  • Using MR Enterography and CT Enterography for Routine Crohn’s Surveillance: How We Do It Now, and How We Hope to Do it in the Future
  • STRIDE-II : an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE)initiative of the International Organization for the Study of IBD(IOIBD). Determining therapeutic goals for treat-to-target strategies in IBD
    Turner D [2021]
  • Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
  • Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease : a systematic review
    Colombel JF [2020]
  • Mucosal healing in inflammatory bowel diseases : a systematic review
    Neurath MF [2012]
  • Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
  • Fibrostenotic strictures in Crohn’s disease
    유준환 [2020]
  • Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan
    Higashi D [2016]
  • Combined endoscopic and radiologic healing is associated with a better prognosis than endoscopic healing only in patients with Crohn’s disease receiving anti-TNF therapy
    Oh K [2022]
  • Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
  • Association of faecal calprotectin level and combined endoscopic and radiological healing in patients with Crohn’s disease receiving anti-tumour necrosis factor therapy
    Noh SM [2020]